News and Resources

Read the latest news

Read Lightcast news, updates and ideas.

Function-focused single-cell analysis to accelerate antibody discovery

Advancing drug development with function-focused profiling at the single-cell level

The benefits of using a droplet environment for antibody discovery

What is a Functional Assay?

Moving Droplets with Light Using oEWOD Technology

The Evolution of Single-Cell Analysis: From flow cytometry to function-focused analysis

Rapid Cell Loading on Envisia

The Advantage of a Closed Cartridge System

Improving Efficiency in the Antibody Development Pipeline

Lightcast Raises $27 Million and Adds Industry Veteran to Accelerate Commercialization of Envisia™ Platform

Single-cell analysis has transformed drug discovery. So why are we still guessing at function?

Four ways Envisia is changing the game in antibody discovery

Lightcast Appoints Industry Veteran Philip Binns as Chairman of the Board

Lightcast Announces Limited Commercial Release of Envisia™ Single-Cell Functional Analysis Platform for Antibody Discovery

What traditional workflows overlook

What is the Poisson Dilemma?

Streamlining drug discovery with function-focused single-cell analysis

Lightcast Publishes Seminal Scientific Paper in “Lab on a Chip”

Lightcast CCO, Paul Steinberg, interviewed by Genomeweb

Lightcast Announces Scientific Advisory Board

Lightcast Opens Innovation Center in United States to Support Global Expansion of Luminary Early Access Program

Lightcast publishes paper describing its light-based technology and application to single-cell functional biology at scale.

Lightcast profiled by Illumina Ventures for their March Portfolio Company Spotlight

Lightcast secures $49 million in Series B financing to commercialize its single-cell platform for functional analysis

Function-focused single-cell analysis to accelerate antibody discovery

Advancing drug development with function-focused profiling at the single-cell level

Single-cell analysis has transformed drug discovery. So why are we still guessing at function?

Four ways Envisia is changing the game in antibody discovery

What traditional workflows overlook

What is the Poisson Dilemma?

Streamlining drug discovery with function-focused single-cell analysis

Lightcast Raises $27 Million and Adds Industry Veteran to Accelerate Commercialization of Envisia™ Platform

Lightcast Announces Limited Commercial Release of Envisia™ Single-Cell Functional Analysis Platform for Antibody Discovery

Lightcast Publishes Seminal Scientific Paper in “Lab on a Chip”

Lightcast Announces Scientific Advisory Board

Lightcast Opens Innovation Center in United States to Support Global Expansion of Luminary Early Access Program

Lightcast secures $49 million in Series B financing to commercialize its single-cell platform for functional analysis

Lightcast Appoints Industry Veteran Philip Binns as Chairman of the Board

Lightcast CCO, Paul Steinberg, interviewed by Genomeweb

Lightcast publishes paper describing its light-based technology and application to single-cell functional biology at scale.

Lightcast profiled by Illumina Ventures for their March Portfolio Company Spotlight

The benefits of using a droplet environment for antibody discovery

What is a Functional Assay?

Moving Droplets with Light Using oEWOD Technology

The Evolution of Single-Cell Analysis: From flow cytometry to function-focused analysis

Rapid Cell Loading on Envisia

The Advantage of a Closed Cartridge System

Improving Efficiency in the Antibody Development Pipeline